(Reuters) - Vaccine makers are shoring up their supply of a critical raw material in "messenger RNA" vaccines: the lipid molecules that help deliver the genetic RNA material into cells.
Manufacturers are under pressure to increase production of COVID-19 vaccines as infections from the pandemic approach 110 million people.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!